Article Versions Notes

Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev EA, Stöhr R, Agaimy A, Reis A, et al. Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. Cancers. 2023; 15(24):5892. https://doi.org/10.3390/cancers15245892

Tögel, Lars, Christoph Schubart, Sebastian Lettmaier, Clemens Neufert, Juliane Hoyer, Kerstin Wolff, Evgeny A Moskalev, Robert Stöhr, Abbas Agaimy, André Reis, and et al. 2023. "Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center" Cancers 15, no. 24: 5892. https://doi.org/10.3390/cancers15245892

Tögel, L., Schubart, C., Lettmaier, S., Neufert, C., Hoyer, J., Wolff, K., Moskalev, E. A., Stöhr, R., Agaimy, A., Reis, A., Wullich, B., Mackensen, A., Pavel, M., Beckmann, M. W., Hartmann, A., Fietkau, R., Meidenbauer, N., Haller, F., & Spoerl, S. (2023). Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. Cancers, 15(24), 5892. https://doi.org/10.3390/cancers15245892